Altria (NYSE: MO) owns the Marlboro brand, which has a roughly 41% market share in North America. That's huge and highlights the company's dominance in this geographic region. But the downside ...

Altria Group, Inc. MO stock is currently trading at a forward 12-month price-to-earnings (P/E) ratio of 9.85, representing a 16.9% discount compared to the Zacks Tobacco industry’s average of 11.85.

Pfizer yields 6.53% and trades at 9x earnings, while Altria offers 7.58% at 10.1x earnings. Pfizer's troubling 221% payout ratio contrasts sharply with Altria's manageable 67.3%. Altria's pricing ...

I went from recommending Altria as a Sell last to now being a Strong Buy, with strong assumptions for its future revenue and earnings. Altria has a margin of safety and its upside has not yet been ...

Dec 19 - A U.S. appeals court on Thursday upheld a $95.2 million jury verdict for tobacco giant Altria (MO.N), opens new tab in a patent dispute with rival R.J. Reynolds over e-cigarette technology.

Altria Group, Inc. (MO) has firmly established itself as a dominant force in the market, largely due to its diverse portfolio of smokeable and oral tobacco products. These products are leading the ...

Altria has a large dividend yield, and its dividend has been growing. The company has a dominant market position in its core market. Altria's cigarette business is mired in a long-term volume ...

I last analyzed Altria Group (NYSE:MO) back in October. That article was titled "Altria: Dividends Still Don't Lie" and argued for a Buy rating with a focus on its dividends. Quote: For dividend ...